Clinical Trials in Salt Lake City

Showing 3941-3960 of 12,670 trials

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

Immune Thrombocytopenia

Sobi, Inc.60 participantsStarted Mar 2021

Tucson, Arizona, United States • Whittier, California, United States • Washington D.C., District of Columbia, United States +17 more locations

Active Not RecruitingPhase 2< 1 mile

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

NCT03709680

A study to learn about safety and find out maximum tolerable dose of palbociclib given in combination with chemotherapy (temozolomide with irinotecan or topotecan with cyclophosphamide) in children, adolescents and young adults with recurrent or refractory solid tumors (phase 1). Neuroblastoma tumor specific cohort to further evaluate antitumor activity of palbociclib in combination with topotecan and cyclophosphamide in children, adolescents, and young adults with recurrent or refractory neuroblastoma. Phase 2 to learn about the efficacy of palbociclib in combination with irinotecan and temozolomide when compared with irinotecan and temozolomide alone in the treatment of children, adolescents, and young adults with recurrent or refractory Ewing sarcoma (EWS).

Ewing SarcomaSolid TumorsRhabdoid Tumor+4 more

Pfizer128 participantsStarted May 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Long Beach, California, United States +98 more locations

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Find Trials by Condition in Salt Lake City

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

CLUSTER Trial for Outbreak Detection and Response

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Saypha® VOLUME Lidocaine for Midface Augmentation

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

The Syn-Sleep Study

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Evaluating Treatment of ADHD in Children with Down Syndrome

International EXPAND Heart Pivotal Trial

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection